Filing Details
- Accession Number:
- 0001551986-18-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-28 18:17:58
- Reporting Period:
- 2018-08-28
- Accepted Time:
- 2018-08-28 18:17:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551986 | Innovate Biopharmaceuticals Inc. | INNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1721664 | Sandeep Laumas | C/O Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC 27615 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-28 | 0 | $4.90 | 250 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-08-28 | 250 | $4.88 | 500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-08-28 | 95 | $5.07 | 595 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-08-28 | 405 | $5.08 | 1,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |